Model-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors.

Model-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors.

Item
http://www.wikidata.org/entity/Q37609771
Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced Melanoma.Fixed Dosing of Monoclonal Antibodies in Oncology.Evaluation of dosing strategy for pembrolizumab for oncology indications.Commentary on Pharmacometrics for Immunotherapy.Pembrolizumab use for the treatment of advanced melanoma.Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma.Population Pharmacokinetics of Durvalumab in Cancer Patients and Association with Longitudinal Biomarkers of Disease Status.Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.Clinical Pharmacology Considerations for the Development of Immune Checkpoint Inhibitors.Optimal pembrolizumab dosing for non-small cell lung cancer: further studies still needed.New developments in the management of head and neck cancer – impact of pembrolizumab.Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response.Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utility.Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia.
P2860

Model-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors.

Item
http://www.wikidata.org/entity/Q37609771
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Model-Based Characterization o ...... body in Advanced Solid Tumors.
@en
Model-Based Characterization o ...... body in Advanced Solid Tumors.
@nl
type
label
Model-Based Characterization o ...... body in Advanced Solid Tumors.
@en
Model-Based Characterization o ...... body in Advanced Solid Tumors.
@nl
prefLabel
Model-Based Characterization o ...... body in Advanced Solid Tumors.
@en
Model-Based Characterization o ...... body in Advanced Solid Tumors.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Model-Based Characterization o ...... body in Advanced Solid Tumors.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932